Reykjavik, ICELAND, October 8, 2008 – deCODE genetics (Nasdaq:DCGN) today announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the ...

deCODE genetics has announced the launch of deCODE BreastCancer™, a new tool for assessing risk of the common forms of breast cancer. For the first time, a woman concerned about breast cancer can ...

deCODE Genetics has announced the launch of deCODE T2™, a DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D). deCODE believes ...

REYKJAVIK, Iceland, Oct. 11 deCODE genetics(Nasdaq: DCGN) today announced the launch of deCODE MI(TM), a referencelaboratory test for variations in the genome (called ...

LONDON, Oct 11 (Reuters) - Icelandic biotech firm Decode Genetics moved deeper into the diagnostics market on Thursday with the launch of a new laboratory test for genetic variations that increase the ...

The testing of advanced video decoders is a daunting task, considering the greater complexity and nonlinearity of H.264 compared with MPEG-2. Decoding depends on numerous contexts and states that one ...